Randall C Schatzman - Net Worth and Insider Trading
Randall C Schatzman Net Worth
The estimated net worth of Randall C Schatzman is at least $2 Million dollars as of 2024-11-13. Randall C Schatzman is the President and CEO of Alder BioPharmaceuticals Inc and owns about 115,172 shares of Alder BioPharmaceuticals Inc (ALDR) stock worth over $2 Million. Randall C Schatzman is also the CEO of Bolt Biotherapeutics Inc and owns about 1,500 shares of Bolt Biotherapeutics Inc (BOLT) stock worth over $945. Details can be seen in Randall C Schatzman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Randall C Schatzman has not made any transactions after 2021-02-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Randall C Schatzman
Randall C Schatzman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Randall C Schatzman owns 1 companies in total, including Bolt Biotherapeutics Inc (BOLT) .
Click here to see the complete history of Randall C Schatzman’s form 4 insider trades.
Insider Ownership Summary of Randall C Schatzman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BOLT | Bolt Biotherapeutics Inc | 2022-02-18 | director & Chief Executive Officer |
Randall C Schatzman Latest Holdings Summary
Randall C Schatzman currently owns a total of 2 stocks. Among these stocks, Randall C Schatzman owns 115,172 shares of Alder BioPharmaceuticals Inc (ALDR) as of February 9, 2017, with a value of $2 Million and a weighting of 99.96%. Randall C Schatzman also owns 1,500 shares of Bolt Biotherapeutics Inc (BOLT) as of February 9, 2021, with a value of $945 and a weighting of 0.04%.
Latest Holdings of Randall C Schatzman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDR | Alder BioPharmaceuticals Inc | 2017-02-09 | 115,172 | 18.88 | 2,174,447 |
| BOLT | Bolt Biotherapeutics Inc | 2021-02-09 | 1,500 | 0.63 | 945 |
Holding Weightings of Randall C Schatzman
Randall C Schatzman Form 4 Trading Tracker
According to the SEC Form 4 filings, Randall C Schatzman has made a total of 0 transactions in Alder BioPharmaceuticals Inc (ALDR) over the past 5 years. The most-recent trade in Alder BioPharmaceuticals Inc is the sale of 30,000 shares on February 9, 2017, which brought Randall C Schatzman around $750,900.
According to the SEC Form 4 filings, Randall C Schatzman has made a total of 1 transactions in Bolt Biotherapeutics Inc (BOLT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bolt Biotherapeutics Inc is the acquisition of 1,500 shares on February 9, 2021, which cost Randall C Schatzman around $30,000.
Insider Trading History of Randall C Schatzman
- 1
Randall C Schatzman Trading Performance
GuruFocus tracks the stock performance after each of Randall C Schatzman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randall C Schatzman is -32.6%. GuruFocus also compares Randall C Schatzman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randall C Schatzman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Randall C Schatzman's insider trading performs compared to the benchmark.
Performance of Randall C Schatzman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.28 | | | | | |
| Relative Return to S&P 500(%) | 6.2 | | | | | |
Randall C Schatzman Ownership Network
Ownership Network List of Randall C Schatzman
Ownership Network Relation of Randall C Schatzman
Randall C Schatzman Owned Company Details
What does Bolt Biotherapeutics Inc do?
Who are the key executives at Bolt Biotherapeutics Inc?
Randall C Schatzman is the director & Chief Executive Officer of Bolt Biotherapeutics Inc. Other key executives at Bolt Biotherapeutics Inc include Chief Financial Officer William P. Quinn , 10 percent owner Vivo Capital Fund Viii, L.p. , and 10 percent owner Novo Holdings A/s .
Bolt Biotherapeutics Inc (BOLT) Insider Trades Summary
Over the past 18 months, Randall C Schatzman made no insider transaction in Bolt Biotherapeutics Inc (BOLT). Other recent insider transactions involving Bolt Biotherapeutics Inc (BOLT) include a net sale of 200,000 shares made by Edgar Engleman , a net sale of 89,454 shares made by Vivo Capital Fund Viii, L.p. , and a net purchase of 11,829 shares made by William P. Quinn .
In summary, during the past 3 months, insiders sold 0 shares of Bolt Biotherapeutics Inc (BOLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 289,454 shares of Bolt Biotherapeutics Inc (BOLT) were sold and 11,829 shares were bought by its insiders, resulting in a net sale of 277,625 shares.
Bolt Biotherapeutics Inc (BOLT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bolt Biotherapeutics Inc Insider Transactions
Randall C Schatzman Mailing Address
Above is the net worth, insider trading, and ownership report for Randall C Schatzman. You might contact Randall C Schatzman via mailing address: 11804 North Creek Parkway South, Bothell Wa 98011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
